Prostavasin | JP | Pharmacopoeia | Reference Standards| PharmaCompass.com

Please Wait

Applying Filters...

Prostavasin

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

18 API Suppliers, 8 USDMF, 2 CEP/COS, 1 JDMF, 2 KDMF, 13 NDC API, 12 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

FINISHED DOSAGE FORMULATIONS

77 FDF Dossiers, 23 FDA Orange Book, 41 Europe, 3 Canada, 2 Australia, 2 South Africa, 6 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 0.005MG/VIAL, INJECTABLE;INJECTION - 0.01MG/VIAL, INJECTABLE;INJECTION - 0.02MG/VIAL, INJECTABLE;INJECTION - 0.04MG/VIAL

RELATED EXCIPIENT COMPANIES

1 Nanjing Well Pharmaceutical, 4 Actylis, 2 BASF, 1 Finar, 3 Kerry, 1 Roquette

EXCIPIENTS BY APPLICATIONS

4 Parenteral, 3 Co-Processed Excipients, 2 Direct Compression, 2 Topical, 2 Granulation, 1 Fillers, Diluents & Binders, 1 Coating Systems & Additives, 1 Solubilizers, 1 Controlled & Modified Release

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 31 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 30 Finished Drug Prices

MARKET PLACE

25 APIs, 7 FDF Dossiers

PATENTS & EXCLUSIVITIES

14 Health Canada Patents

14 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 4 JP, 1 Others

$ Xls

Filters

Filters

FILTER :

filter Reference Standard Reset all filters

4 All

01 4Alprostadil

filter Monograph in Japanese Pharmacopoeia Reset all filters

Product Main Page

01

Japanese Pharmacopoeia

Japan

Medlab Asia & Asia Health

Not Confirmed

02

Japanese Pharmacopoeia

Japan

Medlab Asia & Asia Health

Not Confirmed

03

Japanese Pharmacopoeia

Japan

Medlab Asia & Asia Health

Not Confirmed

04

Japanese Pharmacopoeia

Japan

Medlab Asia & Asia Health

Not Confirmed

Contact us
to update this info